Arabilin overcomes resistance to AR-targeted therapy

被引：0
|
作者：
Takahiro Fujimaki
Shun Saito
Masaya Imoto
机构：
[1] Faculty of Science and Technology,Department of Biosciences and Informatics
[2] Keio University,undefined
来源：
The Journal of Antibiotics | 2017年 / 70卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：328 / 330
页数：2
相关论文
共 50 条
  • [21] AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer
    Liu, Chengfei
    Yang, Joy C.
    Armstrong, Cameron M.
    Lou, Wei
    Liu, Liangren
    Qiu, Xiaomin
    Zou, Binhao
    Lombard, Alan P.
    D'Abronzo, Leandro S.
    Evans, Christopher P.
    Gao, Allen C.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1875 - 1886
  • [22] Genomic loss of TP53 impairs AR-targeted activity in metastatic prostate cancer
    Han, Wanting
    Nyquist, Michael D.
    Coleman, Ilsa
    De Sarkar, Navonil
    Ang, Lisa
    Corey, Eva
    Nelson, Peter S.
    CANCER RESEARCH, 2023, 83 (11)
  • [23] Targeted chemotherapy overcomes drug resistance in melanoma
    Yue, Jingyin
    Vendramin, Roberto
    Liu, Fan
    Lopez, Omar
    Valencia, Monica G.
    Dos Santos, Helena Gomes
    Gaidosh, Gabriel
    Beckedorff, Felipe
    Blumenthal, Ezra
    Speroni, Lucia
    Nimer, Stephen D.
    Marine, Jean-Christophe
    Shiekhattar, Ramin
    GENES & DEVELOPMENT, 2020, 34 (9-10) : 637 - 649
  • [24] MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer
    Wu, Yutuan
    Huang, Jie
    Ivan, Cristina
    Sun, Yunjie
    Ma, Shaolin
    Mangala, Lingegowda S.
    Fellman, Bryan M.
    Urbauer, Diana L.
    Jennings, Nicholas B.
    Ram, Prahlad
    Coleman, Robert L.
    Hu, Wei
    Sood, Anil K.
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 181 - 190
  • [25] A new targeted combination therapy overcomes the acquired resistance of colorectal cancer stem cells
    Benfante, A.
    Mangiapane, L. R.
    Colorito, M. L.
    Gaggianesi, M.
    Nicotra, A.
    Giammona, A.
    Scavo, E.
    Chinnici, A.
    Todaro, M.
    Stassi, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S47 - S48
  • [26] Correlating whole blood AR-V7 and AR-V9 with therapy response to AR-targeted therapies in metastatic castrate-resistant prostate cancer (mCRPC).
    Kwan, Edmond Michael
    To, Sarah Q.
    Fettke, Heidi C.
    Mant, Andrew Michael
    Docanto, Maria M.
    Bukczynska, Patricia
    Ng, Nicole
    Graham, Lisa-Jane K.
    Parente, Phillip
    Pezaro, Carmel Jo
    Mahon, Kate Lynette
    Horvath, Lisa
    Todenhofer, Tilman
    Azad, Arun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics
    Effah, Wendy
    Khalil, Marjana
    Hwang, Dong-Jin
    Miller, Duane D.
    Narayanan, Ramesh
    STEROIDS, 2024, 210
  • [28] Liquid biopsy AR/enhancer alteration detection before AR-targeted therapy and correlation with survival in metastatic castrate-resistant prostate cancer patients.
    Shiang, Alexander
    Chauhan, Pradeep S.
    Dang, Ha X.
    Webster, Jace
    Ledet, Elisa M.
    Babbra, Ramandeep K.
    Feng, Wenjia
    Harris, Peter K.
    Jaeger, Ellen B.
    Miller, Patrick
    Caputo, Sydney
    Santos, Giordano Fabricio Cittolin
    Pachynski, Russell Kent
    Sartor, A. Oliver
    Maher, Christopher
    Chaudhuri, Aadel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [29] TAS3681, a new type of androgen receptor antagonist, disrupts aberrant AR signaling that drives tumor resistance to AR-targeted therapies by downregulating full-length and splice variant AR
    Kajiwara, D.
    Minamiguchi, K.
    Seki, M.
    Mizutani, H.
    Yamamura, K.
    Okajima, S.
    Sasaki, E.
    Utsugi, T.
    Iwasawa, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S127 - S127
  • [30] Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance (vol 3, pg 1071, 2022)
    Deng, Su
    Wang, Choushi
    Wang, Yunguan
    Xu, Yaru
    Li, Xiaoling
    Johnson, Nickolas A.
    Mukherji, Atreyi
    Lo, U-Ging
    Xu, Lingfan
    Gonzalez, Julisa
    Metang, Lauren A.
    Ye, Jianfeng
    Tirado, Carla Rodriguez
    Rodarte, Kathia
    Zhou, Yinglu
    Xie, Zhiqun
    Arana, Carlos
    Annamalai, Valli
    Liu, Xihui
    Vander Griend, Donald J.
    Strand, Douglas
    Hsieh, Jer-Tsong
    Li, Bo
    Raj, Ganesh
    Wang, Tao
    Mu, Ping
    NATURE CANCER, 2022, 3 (10) : 1271 - 1271
12345